NRL News
202.626.8800
dadandrusk@aol.com

When “choice” only goes one way

Jul 27, 2026

By Andrea Trudden

 

A coalition of 23 attorneys general, led by New York Attorney General Letitia James, recently urged a federal appeals court to reject an effort to reinstate previous FDA safeguards governing the abortion drug mifepristone. In their filing, they argue that mifepristone has a well-established safety record and that women should continue to have access to the drug without additional restrictions.

 

The argument is rooted in a familiar principle: women deserve the freedom to make their own healthcare decisions.

 

But that principle raises an important question.

 

If women deserve access to information before taking mifepristone, why are many of these same attorneys general working to prevent women from receiving information after taking it?

 

That question lies at the center of another lawsuit AG James has launched against Heartbeat International, CompassCare, and other pregnancy help organizations.

 

James alleges that pregnancy help organizations violate state consumer protection laws by telling women about Abortion Pill Reversal (APR), a perfectly legal medical protocol that may help women who regret taking the first drug in a chemical abortion to continue their pregnancies.

 

Heartbeat and its co-plaintiffs have challenged the attorney general’s actions, arguing that the state is violating their constitutional rights by attempting to silence protected speech and restrict women from receiving information about a lawful medical option.

 

The hypocrisy is difficult to ignore.

 

On one hand, New York argues that women should have broad access to mifepristone because they are capable of making informed medical decisions. On the other hand, the same attorney general seeks to prevent women who immediately regret taking that first pill from learning there may still be another option available through a licensed medical professional.

 

This is not simply a disagreement over reproductive medicine. It is a question of whether the government may decide what information women are permitted to hear.

 

The litigation against Heartbeat International did not emerge in isolation.

 

In 2023, a coalition of Democratic attorneys general, led by California Attorney General Rob Bonta, publicly accused pregnancy help organizations of misleading consumers. They urged Google to place warning labels on pregnancy centers, questioned the medical services many centers provide, and criticized APR as “unproven.” Those public accusations marked one of the first coordinated efforts by state attorneys general to challenge the work of pregnancy help organizations nationwide.

 

Since then, that campaign has expanded well beyond public statements.

 

In 2023, California Attorney General Bonta launched his legal attack against Heartbeat and RealOptions while asking the court to prohibit them from speaking about APR. The state is seeking nearly $20 million in penalties–damages that pose an existential threat to Heartbeat’s ministry. The next year, New York followed in California’s footsteps and filed its own lawsuit with the same legal theory.

 

And in New Jersey, another dispute has reached the nation’s highest court.

 

Earlier this year, the U.S. Supreme Court unanimously ruled that First Choice Women’s Resource Centers could pursue its constitutional challenge against former New Jersey Attorney General Matthew Platkin in federal court after his office sought extensive donor and organizational records through an investigative subpoena. While the case concerns donor privacy rather than speech about APR, the Court’s decision recognized that government actions directed at pregnancy help organizations can implicate core First Amendment protections long before any enforcement action is complete.

 

Viewed together, these cases reveal a growing constitutional challenge. Across multiple states, attorneys general have increasingly relied on consumer protection laws, investigative powers, subpoenas, and litigation to challenge pregnancy help organizations and the viewpoints they express. Whether the issue is donor privacy, organizational communications, or APR, the underlying question is becoming the same: Should the government have the ability to leverage regulatory authority against a nonprofit simply because it disagrees with the organization’s message?

 

That question is central to Heartbeat’s cases in both New York and California.

 

Heartbeat has never argued that every woman should pursue APR. Nor has it claimed that every physician should provide it.

 

Instead, Heartbeat has consistently maintained that women deserve truthful information about all their lawful medical options so they can consult with qualified healthcare professionals and make informed decisions.

 

That should not be controversial.

 

 

Every day, women contact the Abortion Pill Rescue® Network (APRN) after taking mifepristone because they regret beginning a chemical abortion. Some felt pressured. Others believed they had no other choice.

 

For these women, time is critical.

 

The APRN exists because thousands of women have searched for help during that window. Today, statistics show that more than 8,000 lives have been saved after their mothers contacted the network to seek information and treatment from participating medical professionals.

 

These women made a new decision. Should the government decide they are no longer entitled to hear about their options?

 

The coalition of attorneys general argues that preserving access to mifepristone protects women’s autonomy. But autonomy does not end the moment a woman starts the abortion process.

 

Ultimately, these lawsuits are about far more than APR.

 

They ask whether government officials may suppress lawful speech because they disagree with its message. They concern whether pregnancy help organizations may continue providing women with truthful information about lawful medical options. And they concern whether the First Amendment protects the right of ministries and medical professionals to speak freely without fear of government retaliation.

 

Perhaps most importantly, they ask whether a woman’s freedom to choose truly includes the freedom to change her mind.

 

If choice matters before the first abortion pill, it should matter afterward as well.

 

Editor’s note: Heartbeat International manages the Abortion Pill Rescue® Network (APRN) and Pregnancy Help News where this first appeared. Reposted with permission. Heartbeat is currently the subject of two lawsuits brought by state attorneys general concerning sharing information about Abortion Pill Reversal.

 

Categories: heartbeat sued
Tags: